APA (7th ed.) Citation

R, L., ZA, W., SE, R., AB, P., M, G., K, A., . . . MW, T. (2023). Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. MMWR. Morbidity and mortality weekly report, 72(21), 579. https://doi.org/10.15585/mmwr.mm7221a3

Chicago Style (17th ed.) Citation

R, Link-Gelles, et al. "Estimates of Bivalent MRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023." MMWR. Morbidity and Mortality Weekly Report 72, no. 21 (2023): 579. https://doi.org/10.15585/mmwr.mm7221a3.

MLA (9th ed.) Citation

R, Link-Gelles, et al. "Estimates of Bivalent MRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023." MMWR. Morbidity and Mortality Weekly Report, vol. 72, no. 21, 2023, p. 579, https://doi.org/10.15585/mmwr.mm7221a3.